In this session, you'll learn how to:

• Create a culture of safety in a healthcare organization.
• Describe the role of technology in prevention of medical errors.
• Discuss selected strategies for error reduction and prevention.

Robert T. Hasty, DO, FACOI, FACP, Dean & Chief Academic Officer, Orlando College of Osteopathic Medicine (Proposed)

Identify Types of Wounds and Wound classification for different types of wounds

Physiology of wound healing

Six Basic elements of wound care and wound care coordination

Glenn D. Haraway, DO, FACOI, Owner, Tulsa Vein Institute

Understanding development of new criteria on destination therapy

New consideration in clinical management of complex cases

Results of heart transplant 

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

Understanding the new techn sciences

Trials finding improved performance over the std troponin
Clinical use in practice

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you'll learn how to:

• Understand the differences between VV-ECMO and VA-ECMO
• Discuss the major indications for VV-ECMO consideration/usage
• Discuss complications that can be seen in VV-ECMO and VA-ECMO

Joan C. Wiley, DO, FACOI, Medical Director, Jefferson University Hospital ICU-Stratford, Cherry Hill Divisions

(60 mins)

In this session, you'll learn how to:

• Heart Failure With Reduced LV Function (HFrEF) Guidelines Update and What’s New in 2021-2022
• Where we are at with Heart Failure with Preserved LV Function (HFpEF)and discuss the current and past clinical trials from 2003-2022
• Previous and recent clinical trials for patients presenting with acute CHF and current treatment recommendations for hospitalized patients with CHF

Chad A. Link, DO, FACC, FACOI, Cardiologist, University of Michigan Health- Sparrow

In this session, you'll learn how to:

• Review several modifiable risk factors that contribute to AF and AF burden.
• Guideline-directed first-line use of direct-acting oral anticoagulants (DOACs) as first-line therapies to prevent stroke or systemic embolism associated with atrial fibrillation.
• Discuss emerging anticoagulation therapies for VTE and AF

Chad A. Link, DO, FACC, FACOI, Cardiologist, University of Michigan Health- Sparrow

In this session, you'll learn how to:

• Understand the role of over-prescribing in driving the opioid epidemic
• Discuss the role of safe opioid prescribing and administration
• Analyze the drivers of opioid addiction and how to address it

Holly L. Geyer, MD, Division Research Coordinator, Mayo Clinic

In this session, you'll learn how to:

• Discuss common denial reasons
• Describe denial avoidance strategies
• Demonstrate communication techniques with case examples

Ariana L. Peters, DO, FACOI, Medical Director, Care Management, Mayo Clinic Arizona